ImmunologybioRxiv
Preclinical study of DNA vaccines targeting SARS-CoV-2
H. Hayashi, J. Sun, Y. Yanagida…·H. Nakagami
This study evaluates a DNA vaccine targeting SARS-CoV-2 Spike protein, showing enhanced humoral and cellular immune responses and neutralizing antibody activity.
DOI 10.1016/j.retram.2022.103348